stars 1 stars 2 stars 3

At ByBug, we are redefining how the world produces therapeutic proteins. Our breakthrough lies in a new paradigm of biomanufacturing: a platform powered by genetically enhanced Hermetia illucens larvae engineered to produce recombinant proteins and veterinary therapeutics with unprecedented efficiency. By transforming insect larvae into next-generation biofactories, we enable a production model that is 100× more cost-effective and up to 150× more sustainable than conventional systems—unlocking a future where life-saving and life-enhancing biomolecules can be manufactured at scale, with minimal environmental impact. We are not just improving biomanufacturing. We are reinventing it.

ByBug Questions

Gerardo Bluske is the Co-Founder and CEO North America of ByBug.

13 people are employed at ByBug.

ByBug is based in Coquimbo, Coquimbo.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users